Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human epidermal growth factor eye drops in moderate dry eye with superficial punctate keratopathy
CTR20130920Phase 2Active
- Sponsor
- Guilin Huanuowei Gene Pharmaceutical
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of nepidermin in dry eye syndrome (DED), superficial punctate keratitis (SPK), sponsored by Guilin Huanuowei Gene Pharmaceutical. Started Sep 2015; status: active.
02
Drugs
nepidermin
03
Conditions
dry eye syndrome (DED)superficial punctate keratitis (SPK)
Beyond the preview
Go deeper on CTR20130920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130920.